Modulair (Montelukast)

Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1 on airway smooth muscle and inflammatory cells. This inhibition prevents leukotriene‑mediated bronchoconstriction and reduces airway inflammation, helping to keep the airways open and less reactive.

The appropriate dose of Modulair is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for montelukast in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing Modulair to pregnant or nursing individuals, and discuss alternative options when appropriate.

To request Modulair, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Modulair (montelukast) belongs to the leukotriene receptor antagonist class, which works by a different mechanism than inhaled corticosteroids or beta‑agonists. It is often used as an add‑on therapy for patients who need additional control or who experience exercise‑induced symptoms, offering an oral alternative to inhaled medications.

Modulair should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture and direct sunlight to maintain stability and potency throughout the shelf life.

Modulair is taken orally, usually as a single tablet each day. It can be swallowed with or without food, according to the prescriber’s instructions. Consistency in the time of day helps maintain steady drug levels.

Serious adverse events, although rare, include severe allergic reactions such as rash or angioedema, mood changes including depression or suicidal thoughts, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience any of these symptoms.

Modulair is contraindicated in individuals with known hypersensitivity to montelukast or any of the tablet’s excipients. It should also be used with caution in patients with severe hepatic impairment and those taking medications that strongly affect its metabolism.